| Schedule of Segment Reporting Information |
The following tables set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the Company’s unaudited condensed consolidated statements of operations as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended June 30, 2026 |
|
|
Pharmacy Solutions |
|
|
Provider Services |
|
|
Total Segments |
|
Products revenue |
$ |
3,407,173 |
|
|
$ |
— |
|
|
$ |
3,407,173 |
|
Services revenue |
|
— |
|
|
|
465,967 |
|
|
|
465,967 |
|
Cost of drugs |
|
2,916,899 |
|
|
|
— |
|
|
|
2,916,899 |
|
Cost of services |
|
— |
|
|
|
271,402 |
|
|
|
271,402 |
|
Other direct costs (1) |
|
192,093 |
|
|
|
— |
|
|
|
192,093 |
|
Segment selling, general, and administrative expenses (2) |
|
143,612 |
|
|
|
128,515 |
|
|
|
272,127 |
|
Segment depreciation and amortization expense (3) |
|
25,480 |
|
|
|
8,811 |
|
|
|
34,291 |
|
Segment EBITDA |
$ |
180,049 |
|
|
$ |
74,861 |
|
|
$ |
254,910 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended June 30, 2025 |
|
|
Pharmacy Solutions |
|
|
Provider Services |
|
|
Total Segments |
|
Products revenue |
$ |
2,790,101 |
|
|
$ |
— |
|
|
$ |
2,790,101 |
|
Services revenue |
|
— |
|
|
|
357,597 |
|
|
|
357,597 |
|
Cost of drugs |
|
2,377,477 |
|
|
|
— |
|
|
|
2,377,477 |
|
Cost of services |
|
— |
|
|
|
216,444 |
|
|
|
216,444 |
|
Other direct costs (1) |
|
178,925 |
|
|
|
— |
|
|
|
178,925 |
|
Segment selling, general, and administrative expenses (2) |
|
136,040 |
|
|
|
91,871 |
|
|
|
227,911 |
|
Segment depreciation and amortization expense (3) |
|
27,033 |
|
|
|
7,174 |
|
|
|
34,207 |
|
Segment EBITDA |
$ |
124,692 |
|
|
$ |
56,456 |
|
|
$ |
181,148 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended June 30, 2026 |
|
|
Pharmacy Solutions |
|
|
Provider Services |
|
|
Total Segments |
|
Products revenue |
$ |
6,578,522 |
|
|
$ |
— |
|
|
$ |
6,578,522 |
|
Services revenue |
|
— |
|
|
|
908,339 |
|
|
|
908,339 |
|
Cost of drugs |
|
5,589,692 |
|
|
|
— |
|
|
|
5,589,692 |
|
Cost of services |
|
— |
|
|
|
532,326 |
|
|
|
532,326 |
|
Other direct costs (1) |
|
389,875 |
|
|
|
— |
|
|
|
389,875 |
|
Segment selling, general, and administrative expenses (2) |
|
300,646 |
|
|
|
250,937 |
|
|
|
551,583 |
|
Segment depreciation and amortization expense (3) |
|
50,808 |
|
|
|
15,765 |
|
|
|
66,573 |
|
Segment EBITDA |
$ |
349,117 |
|
|
$ |
140,841 |
|
|
$ |
489,958 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended June 30, 2025 |
|
|
Pharmacy Solutions |
|
|
Provider Services |
|
|
Total Segments |
|
Products revenue |
$ |
5,322,272 |
|
|
$ |
— |
|
|
$ |
5,322,272 |
|
Services revenue |
|
— |
|
|
|
703,555 |
|
|
|
703,555 |
|
Cost of drugs |
|
4,525,053 |
|
|
|
— |
|
|
|
4,525,053 |
|
Cost of services |
|
— |
|
|
|
427,989 |
|
|
|
427,989 |
|
Other direct costs (1) |
|
359,564 |
|
|
|
— |
|
|
|
359,564 |
|
Segment selling, general, and administrative expenses (2) |
|
251,778 |
|
|
|
181,973 |
|
|
|
433,751 |
|
Segment depreciation and amortization expense (3) |
|
54,541 |
|
|
|
13,943 |
|
|
|
68,484 |
|
Segment EBITDA |
$ |
240,418 |
|
|
$ |
107,536 |
|
|
$ |
347,954 |
|
(1)Other direct costs primarily includes direct labor costs, delivery costs, insurance, and depreciation and amortization expense that relates to revenue-generating assets. (2)Segment selling, general, and administrative expense includes indirect labor costs, depreciation and amortization, insurance, rent, lease, supplies, professional services, maintenance, repairs, utilities, and communications expense. (3)Total segment depreciation and amortization expense is presented in other direct costs, costs of services, and segment general and administrative expenses, based on the associated asset.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Reconciliation of income: |
|
|
|
|
|
|
|
|
|
|
|
|
Total Segment EBITDA |
|
$ |
254,910 |
|
|
$ |
181,148 |
|
|
$ |
489,958 |
|
|
$ |
347,954 |
|
Segment depreciation and amortization |
|
|
34,291 |
|
|
|
34,207 |
|
|
|
66,573 |
|
|
|
68,484 |
|
Expenses not allocated at segment level: |
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general, and administrative expenses |
|
|
83,096 |
|
|
|
90,752 |
|
|
|
157,601 |
|
|
|
165,987 |
|
Depreciation and amortization |
|
|
7,132 |
|
|
|
7,632 |
|
|
|
13,944 |
|
|
|
14,187 |
|
Interest expense, net |
|
|
36,879 |
|
|
|
38,778 |
|
|
|
75,494 |
|
|
|
80,541 |
|
Income tax expense |
|
|
6,908 |
|
|
|
1,238 |
|
|
|
15,459 |
|
|
|
998 |
|
Net income from continuing operations |
|
$ |
86,604 |
|
|
$ |
8,541 |
|
|
$ |
160,887 |
|
|
$ |
17,757 |
|
|